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We present evidence for a temporal control of GABAergic neurotransmitter specification in the basal forebrain orchestrated by the LIM-
homeodomain factor Lhx7. In Xenopus, using in vivo overexpression experiments, we show that x-Lhx7 and x-Nkx2.1 inhibit GABAergic
specification in the Dlx-expressing areas of the forebrain (subpallium and diencephalon). In addition, x-Lhx7 almost totally represses
GABAergic differentiation at early but not late embryonic stages in subpallial mouse primary neurons in culture, indicating that x-Lhx7 is not
able to withdraw the GABAergic phenotype once it is acquired. Moreover, anatomical data show striking correlations between x-Lhx7
expression and the GABAergic/cholinergic phenotypes. These functional and anatomical observations suggest a sequential role for x-Lhx7 in
neurotransmitter specification. Thus, x-Lhx7 would first prevent a pool of cells to become GABAergic early in development and then promote
cholinergic differentiation later on in this pool. We propose two distinct modulatory roles for a single LIM-hd factor, depending on the
developmental time window.
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A current model of forebrain development proposes that
the identity of the major subdivisions is established in the
telencephalic progenitor zones by regionalized expression of
transcription factors, which are also responsible for the
production of neurons with specific neurotransmitter pheno-
types (Wilson and Rubenstein, 2000). Hence, the Pax6/Ngn1/
2-expressing pallium generates glutamatergic neurons, where-
as the Dlx/Mash1-expressing subpallium produces GABAer-
gic and cholinergic cells. Then waves of radial (for projection
neurons) and tangential (for interneurons) migrations populate
telencephalic subdivisions with appropriate neuronal types
(Marin and Rubenstein, 2001; Parnavelas, 2000). In particu-
lar, the Nkx2.1-positive area (medial ganglionic eminence:
mge, and anterior entopeduncular/preoptic areas: aep/poa)
originates cortical and striatal GABA interneurons and striatal0012-1606/$ - see front matter D 2005 Published by Elsevier Inc.
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al., 2000; Wichterle et al., 2001).
The transcription factors responsible for subpallial neuronal
patterning begin to be discovered. Ectopic expression of
Mash1 in the cortex induces ectopic Dlx1 and GAD67
(glutamic acid decarboxylase) (Fode et al., 2000) and so does
ectopic expression of Dlx2/5 (Stuhmer et al., 2002), suggesting
that Dlx genes are able to induce a GABAergic phenotype. In
addition, the LIM-homeodomain (LIM-hd) factor Lhx6, which
is expressed in the mge/aep/poa (Grigoriou et al., 1998) under
control of Nkx2.1 (Sussel et al., 1999), regulates the decision of
an mge cell to migrate tangentially towards the cortex—but
does not specify its GABAergic phenotype (Alifragis et al.,
2004; Lavdas et al., 1999). On the other hand, the specification
of cholinergic neurons is under control of another mge/aep/
poa-specific LIM-hd factor, Lhx7/Lhx8 (Grigoriou et al., 1998;
Matsumoto et al., 1996). While anatomical evidences show a
striking correlation between Lhx7 expression and the cholin-
ergic phenotype (Asbreuk et al., 2002; Marin et al., 2000),
nearly all forebrain cholinergic cells are absent in Lhx7/
mice, although their initial specification is preserved (Mori et91 (2006) 218 – 226
www.e
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cholinergic specification seems also conserved in fish and
amphibians (Alunni et al., 2004; Moreno et al., 2004).
Recently, a role for Lhx7 in the control of GABAergic
phenotype has also been suggested in vitro (Manabe et al.,
2005).
LIM-hd family members have roles in various aspects of
neuronal specification, such as axonal pathfinding, migration,
or neurotransmitter choice (Hobert and Westphal, 2000;
Shirasaki and Pfaff, 2002). Moreover, they are often expressed
in the differentiating zones of the neuroepithelium, and their
expression patterns respect the boundaries of subdivisions
imposed by regionalizing factors, suggesting that they are well
placed to serve as intermediates between early regional
specification and neuronal specification (Bachy et al., 2001,
2002; Retaux et al., 1999). Here, we directly investigated the
possibility that x-Lhx7 is an intermediate between basal
forebrain regionalization and neuronal specification, i.e.,
between x-Nkx2.1 and GABAergic/cholinergic specification.
Using overexpression experiments in Xenopus embryos to-
gether with anatomical analyses and mouse neuronal primary
cultures, we present evidence that x-Lhx7 has a role in
forebrain neuronal specification. We propose that the early
inhibitory action of x-Lhx7 on GABAwould preserve a pool of
future cholinergic neurons, which differentiate very late in
development, to become GABAergic.
Materials and methods
In situ hybridization
Antisense digoxigenin RNA probes were synthesized according to the
protocol described in Bachy et al., 2001. Embryos (staged according to the
table of Nieuwkoop and Faber) were fixed overnight at 4-C in MEMFA and
maintained in absolute methanol at 20-C until use. After progressive re-
hydration and pretreatments, hybridization step was carried out with 1 Ag of a
digoxigenin-labeled RNA probe, in a 50% formamide containing medium
overnight at 55-C. Hybridization was detected using an alkaline phosphatase-
coupled anti-digoxigenin antibody (Roche Diagnostics, Mannheim, Germany,
dilution 1:1500). Alkaline phosphatase staining was developed with NBT/BCIP
for a purple staining or Fast Red for an orange/fluorescent staining (Roche
Diagnostics, Mannheim, Germany).
Immunofluorescence
Whole mount fixed embryos (up to st. 42) or dissected brains (for older
embryos and larvae) were blocked in PBT (PBS/0.5% Triton/0.5% BSA)
containing 5% fetal veal serum during 1 h at room temperature. The primary
antibodies were added overnight at 4-C at the following dilutions: rabbit anti-
GABA (Sigma), 1/1000; mouse anti-myc (monoclonal 9E10, Sigma), 1/1000;
mouse anti-GFP (Roche), 1/500. After several washes in PBT, the secondary
antibodies (Molecular Probes) were added 2 h at room temperature and washed
again. In case of double immuno-ISH labeling, ISH were performed first (see
above for details), embryos were postfixed 1 h in MEMFA, and processed for
immunolabeling according to the same protocol.
For in toto views, brains were dissected out and mounted in PPD glycerol.
For sectioning, fluorescently labeled embryos or brains were embedded in PBS
containing 4% agar, incubated in PBS containing 4% paraformaldehyde
overnight at 4-C, and sectioned at 30–40 Am on a vibratome (Leica). The
sections were mounted in PPD glycerol. Confocal images were obtained on a
Leica SP2 microscope, and classical fluorescence microscopy was performed
on a Nikon E800 microscope equipped with a DXM1200 camera. Images were(occasionally) corrected for brightness/contrast and mounted into figures using
Adobe Photoshop.
Expression constructs
Full-length x-Lhx7 cDNA was obtained by 5V- and 3V-Race-PCR (Smart-
Race cDNA amplification kit, Clontech). The deduced coding sequence was
amplified with the following primers: forward GGCAGGGCCATGTATTG-
GAAGAG, reverse CCTTTTAAGCGTTGACTTATTGGTAGGTG and sub-
cloned into pGEM-T easy (Promega). An EcoRI-SpeI 1.2 kb full-length x-Lhx7
fragment was then inserted in frame into the pCS2-MT (myc-tag) expression
vector (from David Turner). The x-Nkx2.1 expression vector was obtained by
subcloning an 1.6 kb EcoRI-ApaI fragment from the full-length x-Nkx2.1
cDNA (gift of Paul Krieg) into the pCS2 vector (David Turner). For co-
injection experiments, the GFP reporter construct was pEGFP-N3 (Clontech).
DNA injections into 4/8 cell stage Xenopus embryos
DNA expression constructs (Quiagen DNA prep) were injected into
Xenopus embryos at 4 or 8 cell stage, targeting a D1 blastomere fated to the
anterior brain, according to Moody (1987). A volume of about 1 nl containing a
maximum of 500 pg DNAwas injected. For co-injection experiments, the GFP
reporter was present at a 1:2 ratio. Injected embryos were maintained in
MMR0.1 containing gentamycin for further development, anaesthetized in
MS222 (0.4 mg/ml) and fixed in MEMFA at the appropriate stage for further
processing.
Primary culture of mouse subpallial embryonic neurons
Ganglionic eminences from E12 or E16 mouse embryos were dissected
and manually homogenized in HBBS (Gibco) on ice. After centrifugation,
cells were resuspended in neurobasal/B27/glutamax (Gibco) containing h-
mercaptoethanol and antibiotics (Sigma) and plated on polyornithine/laminin-
coated coverslips at a density of 106/well in 24-well plates. Twelve hours
later, cells were transfected with x-Lhx7-myctag or with GFP using
Lipofectamin2000 (Invitrogen) according to the manufacturer’s protocol.
Primary neurons were then maintained in culture until the equivalent of ‘‘E21/
P2’’ (i.e., 9 days in vitro (div) for neurons from E12 and 5 div for neurons
from E16), fixed, and processed for immunohistochemistry. After blocking in
PBT (PBS/0.1%Triton/0.5%BSA), primary antibody (rabbit anti-GABA or
guinea pig anti-VAChT from Chemicon, 1/500; mouse anti-TuJ1 from Sigma,
1/500) was added 48 h at 4-C, followed by secondary antibody. Double
labeling (anti-myc for x-Lhx7-mt transfected cells or anti-GFP for control-
transfected cells) was then performed. Cells were counterstained with DAPI
(Molecular Probes), mounted, and assessed for neurotransmitter phenotype
under fluorescence microscopy.
Results
The definition of subpallial divisions of the developing
Xenopus telencephalon has been previously reported, leading
to the proposal of a lge-like and a mge-like territory on the
basis of gene expression patterns (Bachy et al., 2002). Here,
we re-examined in detail the anatomical relationships of x-
Dll3, x-Nkx2.1, and x-Lhx7 expression domains at early
stages for the purpose of functional considerations relative to
neurotransmitter specification (Figs. 1A–D). In toto staining
for these markers at stage 35 showed a prominent
expression in subpallial and diencephalic regions (Figs.
1A–C). In the subpallium, both x-Nkx2.1 and x-Lhx7
labeled the same region which corresponds to the mge/
aep/poa and is comprised in the x-Dll3-positive area. In the
diencephalon, the band of x-Lhx7 expression was similar
although thinner than x-Dll3, both being included into the
Fig. 1. Expression of x-Dll3, x-Nkx2.1, and x-Lhx7 in embryonic Xenopus forebrain. The x-Nkx2.1 protein and GABA neurotransmitter are visualized by
immunofluorescence (IF), and the x-Lhx7 and x-Dll3 transcripts are detected by in situ hybridization (ISH, red) revealed by Fast Red and observed in fluorescence
(x-Lhx7) or in bright field microscopy (x-Dll3). Panels A–C show lateral views of in toto dissected brains stained with the indicated gene marker at stage 35.
Anterior is left, dorsal is up, and the shape of the brain is outlined by a dotted line for fluorescence pictures. (D) Optical and confocal sections through the basal
telencephalon of stage 35 embryos labeled for x-Dll3 mRNA or double-labeled for x-Nkx2.1 protein and x-Lhx7 mRNA. Dotted lines delineate subdivisions and
neuroepithelial layers. Hyp, hypothalamus; mge, lge, medial and lateral ganglionic eminence; pa, pallium; spa, subpallium; vz/svz/mz, ventricular, subventricular,
and marginal zone.
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expression of x-Lhx7 was observed only in areas expressing
both x-Dll3 and x-Nkx2.1.
Double-labeled sections showed that x-Nkx2.1 is
expressed in the vz/svz/mz of the neuroepithelium, whereas
x-Lhx7 is restricted to the svz/mz, i.e., only in neuroepithe-
lial layers expressing both x-Dll3 and x-Nkx2.1 (Fig. 1D).
Furthermore, confocal examination showed that virtually all
cells expressed both x-Nkx2.1 and x-Lhx7 in the svz/mz
differentiating layers (Fig. 1D), suggesting that an x-Nkx2.1/
x-Lhx7 pathway could be involved in the specification of all
neurons of the mge/aep/poa.
x-Nkx2.1 induces x-Lhx7 expression in the subpallium
To directly test this hypothesis, we performed ectopic
expression experiments by injecting an x-Nkx2.1 expression
vector in Xenopus embryos at the 4/8 cell stage, targeting a
dorsal blastomere fated to the anterior brain and head
(according to the fate map of Moody, 1987). This method
generated mosaic embryos where x-Nkx2.1 ectopic expressing
cells were easy to locate and recognize on immunostained
sections of injected embryos (e. g., Fig. 2A, arrowhead shows
endogenous x-Nkx2.1 expression). X-Nkx2.1 injected embryos
were double labeled for x-Nkx2.1 protein and x-Lhx7 mRNA.
A typical example of results is shown on Fig. 2A, AV, where
the 3 types of encountered cases can be observed on a single
section. Some x-Nkx2.1 ectopic cells located in the ventral
telencephalon (i.e., in the lge) induced x-Lhx7 expression (65%
of ectopic induction, arrow in Fig. 2AV), whereas some did not.
Moreover, x-Nkx2.1 ectopic cells never induced x-Lhx7
expression when they were located in the pallial territory (as
defined by the x-Dll3-negative dorsal half of the section,
double arrow on Fig. 2AV). The head mesenchyme tissue was
also unable to express x-Lhx7 in response to x-Nkx2.1 ectopic
expression (asterisks in Figs. 2AV, B), suggesting that the effect
was brain- and subpallium-specific.Ectopic x-Lhx7 induction by Nkx2.1 ectopic expressing cells
was reproducible in the svz and mz of the subpallial territory
but never in the vz (Fig. 2B). Moreover, ectopic x-Lhx7
induction was often found in groups of cells (Figs. 2C, CV, D),
most probably corresponding to clones of x-Nkx2.1 ectopic
cells, which therefore behave in the same way regarding x-
Lhx7 induction. Overall, these experiments showed that x-
Nkx2.1 is able to induce x-Lhx7 expression in subpallial svz/mz
cells, i.e., x-Dll3-expressing differentiating cells.
GABAergic subpallial neurons develop from xLhx7-negative
areas
In mouse, the mge/aep/poa area is responsible for the
generation of the two major subpallial neuronal types:
GABAergic neurons, which differentiate early, and cholinergic
neurons, which differentiate postnatally. In Xenopus, subpallial
cholinergic cells appear after 3 weeks of development (Lopez
et al., 2002), and we have previously shown that x-Lhx7 is
expressed in cholinergic areas in late larvae and adults (Moreno
et al., 2004). Nothing is known on the development of
GABAergic forebrain neurons in Xenopus.
In Fig. 3, we present the time-course of generation of
telencephalic GABA neurons in Xenopus, relative to x-Lhx7
expression. At stage 32 (Fig. 3A), no GABAergic cells were
detected yet in the telencephalon, whereas x-Lhx7 was already
expressed in the mge/aep/poa. The first GABAergic cells
appeared in the subpallial telencephalon at stage 35–37 in the
lge (Fig. 3B), the expression domains of GABA and x-Lhx7
being exclusive both in the telencephalon and the diencephalon
(data not shown). The same situation holds true at stage 42
(Fig. 3C), which also corresponded to the first detection of
GABA-positive cells migrating towards the pallium (arrow in
Fig. 3C).
Taken altogether, these anatomical data position x-Lhx7 as a
possible modulator in the determination of neuronal phenotype,
as x-Lhx7 early expression corresponds to a GABA negative
Fig. 2. x-Nkx2.1 induces x-Lhx7 expression in the subpallium. Embryos were injected with an x-Nkx2.1 expression construct at 4/8 cell stage and double-labeled for
x-Nkx2.1 (IF, green) and x-Lhx7 (ISH, red) at stage 39–40. (A) Confocal sections through the telencephalon of an injected embryo, where the endogenous
expression of the two genes (endo, vertical arrowheads) is clearly distinguishable from the ectopic expression (here on the left side, in the insets). Like in panel A, the
delineation of pallial and subpallial subdivisions is reported and indicated by dotted lines. (AV) Confocal high power magnification of the ectopic Nkx2.1 cells of the
insets in panel A. The arrow points to a subpallial/lge cell which ectopically expresses x-Lhx7. The double arrow points to a pallial cell which does not express x-
Lhx7. The asterisk indicates an ectopic cell located in the head mesenchyme. (B) Another example of a subpallial x-Nkx2.1 ectopic cell which ectopically induces x-
Lhx7 (arrow, shown at high magnification in the insets). The asterisk indicates groups of ectopic cells located in the head mesenchyme. (C, CV, D) Merged confocal
images of groups of cells most probably corresponding to clones of ectopic cells in the subpallial mz, and which induce x-Lhx7 ectopic expression (CV is a high power
view of cells in the inset in panel C). In all panels, the vertical arrowheads indicate endogenous x-Nkx2.1 expression. See legend of previous figures for anatomical
abbreviations. Quantification was performed on 100 injected embryos, 11 of which presented ectopic cells in the telencephalon. Out of 26 ectopic Nkx2.1-expressing
cells found in the lge area, 17 cells were also Lhx7-positive, thereby representing a 65% induction.
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throughout development, long before these neurons definitive-
ly acquire the cholinergic phenotype characterized by ChAT
expression.
x-Lhx7 prevents GABAergic differentiation in vivo
The induction of GAD after overexpression of Dlx2 or Dlx5
in mouse has been clearly established (Stuhmer et al., 2002).
By contrast, the roles of genes such as Nkx2.1 and Lhx7 in the
acquisition of GABAergic phenotype are unknown. In order to
investigate this aspect, we injected x-Lhx7 and x-Nkx2.1
expression vectors in Xenopus embryos at 4/8 cell stage, and
we tested for the presence or absence of GABA in the ectopic
x-Lhx7- or x-Nkx2.1-expressing cells.
Embryos were injected with an x-Lhx7-myctag fusion
expression vector, and ectopic x-Lhx7-expressing cells were
identified by anti-myc immunofluorescence. Embryos were
fixed and processed at stage 39/40, when GABA neurons are
already numerous in the forebrain of control embryos. We
observed a significant and reproducible deficit in GABAergic
neurons in the injected side of embryos with x-Lhx7 ectopic
cells in the ventral telencephalon or diencephalon (Figs. 4A–
D), A systematic (100%) inhibitory effect was found whenectopic x-Lhx7 cells were located in the region of the
presumptive lge (Figs. 4A–C), previously defined as the x-
Nkx2.1-negative/x-Dll3-positive area of the subpallium (Bachy
et al., 2002). This effect was also observable in the
diencephalon (Fig. 4D) in the thalamus, a region which is
molecularly similar to the lge in terms of Dll3/Nkx2.1
expression.
Finally, because x-Nkx2.1 is able to induce ectopically the
expression of x-Lhx7 in the lge and because x-Lhx7 inhibits
GABAergic differentiation, we sought to investigate the effect
of x-Nkx2.1 on the specification of GABA neurons. To this
end, we injected an x-Nkx2.1 expression construct at 4/8 cell
stage and assayed for the presence of GABA in the x-Nkx2.1
ectopic cells when the embryos reached stage 39/40. In this
case, we co-injected x-Nkx2.1 with a GFP reporter construct to
follow x-Nkx2.1 ectopic cells. Although slightly less efficient
than x-Lhx7, x-Nkx2.1 also inhibited GABA expression in
ectopic cells located in the lge territory (Figs. 4E–H). This
inhibition was observed in 60% of cases (analysis performed
on 20 sections coming from 10 embryos with ectopic cells
located in the lge), a percentage which is compatible with the
partial induction of x-Lhx7 by ectopic x-Nkx2.1. This indicates
that the inhibitory effect of x-Nkx2.1 is most probably
mediated by x-Lhx7. The effect was also strongly detected in
Fig. 3. Anatomical and time-course analysis of GABA and x-Lhx7 expression
in developing Xenopus forebrain. The developmental time-course of GABAer-
gic (GABA, red IF) neurons is followed in the telencephalon of stage 32 (A),
stage 37 (B), and stage 42 (C) embryos, and compared to the expression of x-
Lhx7 (purple, ISH) on transverse sections at the same antero-posterior level in
embryonic Xenopus forebrain. Note that GABA and x-Lhx7 are never
colocalized. Arrows in panel C point to presumptive tangentially migrating
cells. Scale bar, 100 Am. Ba, branchial arches; lge, mge, lateral and medial
ganglionic eminences; pa, pallium; aep/poa, anterior entopeduncular and
preoptic areas.
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was observed (data not shown). Ectopic x-Nkx2.1 had no effect
in the pallium. The specificity of these effects was confirmed
by the lack of effect observed after injection of control vectors
(Figs. 4I, J).
Lhx7 effect on GABAergic specification of mouse primary
neurons occurs only at early stages
x-Lhx7 having a precocious role on GABA phenotype, we
next sought to investigate a potential late role for this factor in
neurotransmitter specification. To address this issue, we
transfected mouse ganglionic eminence primary neuronal
cultures with an x-Lhx7myctag construct either early (E12.5)
or late (E16.5), and we analyzed GABAergic and/or choliner-
gic specification in transfected cells (Figs. 5A, 5C). When cells
were transfected at E12.5, we observed a massive inhibition
(95%) of GABA expression after 9 days in culture (equivalent
‘‘E21/P2’’), a result which is consistent with the inhibition
observed above in vivo in Xenopus. This effect was not due to
a general inhibition of neuronal differentiation, since Lhx7-
transfected cells still expressed TuJ1, a marker for early stages
of neuronal differentiation (Fig. 5A, inset) or NeuN, a markerfor mature neurons (not shown). Conversely, when cells were
transfected at E16.5, x-Lhx7 had no effect, as the percentage of
GABA neurons among transfected cells was similar in GFP- or
x-Lhx7-transfected cells after 5 days in culture (Fig. 5B). These
results confirmed that x-Lhx7 is not able to withdraw the
GABAergic phenotype once it is acquired.
Concerning cholinergic phenotype specification, we did not
observe VAChT immunoreactivity (VAChT, vesicular acetyl
choline transporter) in x-Lhx7-transfected primary neurons
(Fig. 5C). Thus, in our experimental conditions, x-Lhx7 is not
sufficient to induce a cholinergic phenotype.
Based on the present anatomical and experimental evi-
dences, we propose a model highlighting the temporal
variations in the genetic interactions for neurotransmitter
specification during Xenopus forebrain development (Fig. 6).
Discussion
We have investigated some of the genetic pathways for
neuronal specification in the subpallial telencephalon. Our
results establish the LIM-hd family member Lhx7 as an
intermediate between regionalization and cellular specification,
that is, between Nkx2.1-expressing mge and GABAergic
specification. Support for this conclusion comes from several
observations. First, x-Lhx7 is never found in GABAergic cells.
Second, ectopic expression of x-Nkx2.1 is able to induce x-
Lhx7, and both transcription factors inhibit GABAergic
differentiation in the basal forebrain in vivo. Third, Lhx7 is
able to repress the GABAergic phenotype acquisition early in
development but is not able to reverse the GABA phenotype
once already acquired late in development.
As a complementary approach to gene inactivation in
mouse, our overexpression experiments bring a new light on
the function of genes such as Nkx2.1 and Lhx7 in neuronal
specification in the ventral forebrain. Furthermore, our
experimental design allows us to illustrate the time dependence
of the system.
x-Lhx7 prevents GABAergic differentiation: a way to generate
a pool of future cholinergic neurons?
Inhibition of the GABAergic phenotype to promote
another neurotransmitter type has been recently demonstrated
in the spinal cord, where Tlx genes act as selector genes
between GABAergic and glutamatergic fates, two neurotrans-
mitter types which appear early in development (Cheng et al.,
2004). In the forebrain, Lhx7 does not behave as a ‘‘selector’’
gene. Of note, while GABA appears also early in telence-
phalic development, the first forebrain cholinergic neurons
have to ‘‘wait’’ until more than three weeks of development to
express ChAT in Xenopus (Lopez et al., 2002), although they
are most probably born at the same time or even before
GABA neurons. Consequently, we propose a hypothetical
scheme, where the timing is a critical factor for the
specification process to take place properly, and where
GABAergic inhibition occurs as a necessary step for the
cholinergic phenotype differentiation (Fig. 6).
Fig. 4. x-Lhx7 and x-Nkx2.1 inhibit GABA expression in Xenopus forebrain. (A–D) Embryos were injected with an x-Lhx7/myc-tag fusion expression construct at
4/8 cell stage and double-labeled for the myc-epitope (IF, green, left column) and GABA (IF, red, middle column) at stage 39/40. Merged IF pictures are shown in the
right column. Panels A, B, and C show examples of cases where ectopic x-Lhx7 cells were distributed in the telencephalon (injected side is on the left) and where a
clear decrease in GABA staining was observed (the absence of GABA cells is pointed by arrows, compare with the right, non-injected side of the brain, where
GABAergic neurons are pointed by asterisks). Panel D shows a case where ectopic x-Lhx7 cells were found in the diencephalon, causing a decrease in GABA cells in
prosomere p3 (ventral thalamus). The dotted lines indicate the pallio-subpallial boundary in panels A, B, and C and indicate the limits of p3 in panel (D). (E–H)
Embryos were injected with a mixture of GFP- and x-Nkx2.1- expression constructs at 4/8 cell stage and double-labeled for GFP (IF, green, left column) and GABA
(IF, red, middle column) at stage 39/40. Merged IF pictures are shown in the right column. Panels E–H show examples of cases where ectopic x-Nkx2.1 cells were
distributed in the telencephalon (note that some embryos were injected on both sides) and induce a decrease in GABA staining in the region of the lge. The absence
of GABA in injected cells is pointed by arrows, while GABAergic neurons in the contralateral/non-injected side are pointed by asterisks. Panel G shows a case where
ectopic x-Nkx2.1 cells were found in the diencephalon, causing a decrease in GABA cells in prosomere p3 (ventral thalamus). The dotted lines indicate the
boundaries of indicated subdivisions. (I, J) Control experiments where embryos injected with a mixture of the two vectors used in this study (pCS2-myctag +
pEGFP) show no modification of GABA staining pattern, when expressing cells are found in the telencephalon (I) or in the diencephalon (J).
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demonstrate the inhibitory role of x-Lhx7 on GABAergic
differentiation. In addition, the cell culture data show that this
role is exclusively precocious, suggesting that x-Lhx7 inhibits
GABA in the aim to preserve the pool of future cholinergic
cells and not merely to block the GABAergic phenotype in the
mge/aep/poa. Thus, the same gene would modulate two
neurotransmitter pathways to coordinate a sequence of events.The pool of cells generated in Xenopus mge/aep/poa
between st.32 and st.35 expresses x-Dlx/x-Nkx2.1/x-Lhx7. It
seems that this pool of cells, which does not express ChAT yet,
but apparently is unable to produce GABA, is fated to become
the basal forebrain cholinergic neuron (Zhao et al., 2003; Mori
et al., 2004). Even further, at this early developmental stage,
this combination of transcription factors seems to prevent the
early apparition of GABA in the future basal ganglia.
Fig. 5. x-Lhx7 prevents GABAergic specification of mouse ganglionic eminence
primary neurons only at early developmental stage. Panel A shows photomicro-
graphs of mouse primary neurons transfected with x-Lhx7-myctag or GFP
constructs at E12 or E16 and maintained in culture for 5 or 9 days, respectively
(until an equivalent of E21/P2). GABA IF is in red, while myc- or GFP-IF is in
green. Insets show high power magnification pictures of a GFP- and an x-
Lhx7myctag-transfected neuron at E12, together with a double immunofluores-
cence image of a TuJ1-positive (red) x-Lhx7-mt transfected cell. In all panels,
arrowheads indicate non-GABAergic transfected cells, and arrows indicate
GABAergic transfected cells (yellow). Panel B shows the quantification of the
effect, expressed as the percentage of GABA-positive cells among transfected
cells. *P < 0.001, Student’s t test. Quantification was performed on 890 Lhx7mt-
and 1490 GFP-transfected cells at E16, and on 185 Lhx7mt- and 365 GFP-
transfected cells at E12, counted from 2–3 independent culture experiments.
Panel C shows primary neurons transfected with x-Lhx7-myctag or GFP
constructs at E12, and assessed for VAChT immunohistochemistry (IF, orange).
The arrowhead points a cholinergic neuron which differentiated during the 9 days
of culture period. Transfection at E16 gave the same result (data not shown).
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prosomere p3 (or ventral thalamus), which does not express x-
Lhx7, already contains GABA neurons (data not shown). It is
therefore likely that among the x-Dlx/x-Nkx2.1/x-Lhx7 combi-
nation of factors, x-Lhx7 is responsible for the prevention of
early GABA production inside the telencephalon. This
hypothesis, derived from the simple observation of expression
patterns, is reinforced by the ectopic expression experiments
where x-Lhx7 inhibits GABA expression both in the sub-
pallium and the p3 prosomere.
Although we studied the effect of ectopic Lhx7 in the lge
because of its highly similar molecular context when
compared to the mge, we cannot strictly rule out the
possibility that the observed effect is due to an excessive
heterodimerization with the LIM-hd factor Lhx2, which is
also expressed in the lge. In this respect, the GABA inhibition
effect observed in prosomere p3 can be viewed as a strong
evidence for Lhx7 specificity, since p3 does not express Lhx2
but Lhx1/Lhx5 combination of LIM-hd factors. This conclu-
sion is fully consistent with the recent in vitro finding of
Manabe et al. (2005), showing that GABA is augmented after
siRNA experiments. However, the fact that late overexpres-
sion of Lhx7 in primary neuronal cultures at E16 is not able
to revert the GABA phenotype is not in favor of a direct
transcriptional effect of Lhx7.
These observations also suggest a mechanism whereby the
number of progenitors in the x-Nkx2.1-expressing zone is
tightly controlled. According to our confocal images, all
these progenitors seem to express x-Nkx2.1. Everything
happens as if during the first rounds of mitotic cycles
(st.32–35), these progenitors give rise to a progeny which
expresses x-Lhx7, which is consequently unable to produce
GABA and which constitutes the main part of the future
pool of cholinergic neurons. Then the x-Nkx2.1-expressing
progenitors would generate cells which do not express x-Fig. 6. A model for GABAergic and cholinergic specification in Xenopus
forebrain. Panel A is a schematic representation of a section through the basa
telencephalon, highlighting the correspondence between the expression o
transcription factors (left hemisphere) and the specification of neurotransmitte
phenotypes (right hemisphere). The relationship between Dlx and GABA was
proposed by Wilson and Rubenstein (2000), Marin and Rubenstein (2001)
Stuhmer et al. (2002). The link between Lhx7 and cholinergic phenotype was
deduced from Zhao et al. (2003) andMori et al. (2004). Panels B and C depict the
transcription factor cascades and ‘‘cross-talk’’ involved in cholinergic and
GABAergic specification, stressing out the differences between early and late
stages of development. The relationships are not necessarily direct. The red
arrows indicate that Lhx7 has different roles in two distinct pathways, being in a
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GABAergic (Figs. 3C and 6C).
Lhx7/Lhx6 as links between regional and cellular specification
in the Nkx2.1-expression region
Besides its apparent shared function in cholinergic specifi-
cation among tetrapods, x-Lhx7 negatively interferes with the
GABAergic fate (Fig. 6A). Therefore, the ‘‘linear’’ view of
neuronal specification where Nkx2.1 is upstream of Lhx7
(Sussel et al., 1999), itself upstream of ChAT (Mori et al.,
2004; Zhao et al., 2003), and where a parallel pathway exists
where Dlx genes are upstream of GAD (Stuhmer et al., 2002),
is now completed by a cross-talk between these two pathways
(Figs. 6B–C). This role is performed by a LIM-hd gene, Lhx7,
which is thus in a critical position in the gene regulatory
network to function as a link (either positive or negative)
between regional and cellular specification. Data available on
the Lhx7 control of cholinergic phenotype are not sufficient to
conclude on a direct or indirect action of Lhx7 on the ChAT/
VAcht promoter. To address this issue, we performed primary
neuron culture experiments: in our conditions, Lhx7 failed to
induce the cholinergic phenotype assessed either by ChAT or
by VAChT immunolabeling, suggesting that the effect is
probably indirect and/or dependent on additional factors. In
addition, in Lhx7/ mice, cells fated to become cholinergic
neurons are born but fail to differentiate (Zhao et al., 2003).
This observation, together with the present findings showing
that presumptive cholinergic cells in Xenopus express x-Lhx7
during almost 1 month before they express ChAT, suggests that
missing factors are needed to trigger cholinergic phenotype
expression.
In mammals, Lhx6 (Lhx7 paralog) is expressed in the
developing mge and is probably also under Nkx2.1 control
(Grigoriou et al., 1998; Marin et al., 2000; Sussel et al.,
1999). Lhx6 conveys specification information for GABAer-
gic neurons generated in the mge to migrate tangentially into
the cerebral cortex (Alifragis et al., 2004; Lavdas et al.,
1999). Lhx6 therefore also functions as a link between
regional and cellular specification. We were unsuccessful
when searching for a Xenopus ortholog of Lhx6. The
comparison of available data in rodents with our present
results suggests two possibilities. First, a Xenopus ortholog of
Lhx6 does nevertheless exist, and in this case, the x-Lhx7-
negative cells generated from the x-Nkx2.1 progenitors
probably express m-Lhx6 homolog. The second possibility
is that there is no Lhx6 ortholog, although we have observed
GABAergic cells in a migratory position in Xenopus pallium,
and others (Brox et al., 2003) have described GAD-expres-
sing migrated neurons in adult Xenopus. In this case, the
migratory signal for these GABAergic neurons in Xenopus
has to be discovered.
More generally, our previous work had suggested the
existence of several examples of links between regional
identity factors and LIM-hd family members in the forebrain
(Bachy et al., 2001, 2002). It would be interesting to
investigate whether other LIM-hd factors are implicated incross-talks between pathways involved in forebrain neuronal
patterning.
LIM-hd factors and bHLH factors in neuronal specification
Interestingly, Xenopus overexpression experiments uncover
an aspect which cannot be deduced from inactivation experi-
ments in mouse. Hence, ectopic expression of x-Lhx7 induced
by x-Nkx2.1 can exclusively occur in the subpallial telenceph-
alon. The Mash1 factor, which is an important regulator of
neurogenesis in the subpallium, where it is required to specify
neuronal precursors and to control the timing of their
production could play a role in this context (Casarosa et al.,
1999; Yun et al., 2002). Of note, Mash1 also controls the
generation of motoneurons and serotonergic neurons from a
common pool of hindbrain progenitors (Pattyn et al., 2003,
2004). Interestingly, interactions between proneural bHLH and
LIM-hd factors are described since a decade in other various
systems and models (Baer et al., 1997; Ohneda et al., 2000;
Radde-Gallwitz et al., 2004) and are implicated in controlling
neurogenesis across species (Bertrand et al., 2002). In the
chicken nervous system, the LIM-hd factors Isl1 and Lhx3
together with the bHLH factors Ngn2 and NeuroM synchronize
the exit from the cell cycle and the specification of spinal
motoneurons (Lee and Pfaff, 2003, 2004). In the chick and
mouse roof plate, Lmx1a/b and Cash1 play a similar role in
dorsal interneuron fate specification (Chizhikov and Millen,
2004a,b). All these studies point out the importance of the
timing in the neuronal specification process. In the basal
forebrain, Yun et al. have proposed that early neurogenesis
depends on Mash1, whereas late neurogenesis is Dlx-depen-
dent (Yun et al., 2002). In addition, telencephalic cholinergic
neurons are largely reduced in Mash1/ mutants (Marin et al.,
2000). These data strongly support our present model that,
although they differentiate late, cholinergic neurons are born
very early in development (Brady et al., 1989; Semba and
Fibiger, 1988).
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